African Journal of Paediatric Surgery About APSON | PAPSA  
Home About us Current issue Search Archives Ahead Of Print Subscribe Instructions Submission Contact Login 
Users Online: 78Print this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 
ORIGINAL ARTICLE
Year : 2010  |  Volume : 7  |  Issue : 3  |  Page : 159-162

Challenges and outcome of Wilms' tumour management in a resource-constrained setting


1 Department of Paediatric Surgery, Paediatric Surgical Center, Amsterdam, The Netherlands
2 Department of Surgery, Queen Elizabeth Central Hospital, Blantyre, Malawi
3 Department of Paediatrics, Queen Elizabeth Central Hospital, Blantyre, Malawi

Correspondence Address:
J.C.H Wilde
Paediatric Surgical Center, 1105 AZ Amsterdam
The Netherlands
Login to access the Email id


DOI: 10.4103/0189-6725.70416

PMID: 20859020

Get Permissions

Background: To review the results of Wilms' tumour patients in a tertiary referral hospital in a developing country and to find ways of improving long-term survival. Patients and Methods: Between January 1998 and May 2004, 40 patients with Wilms' tumour (WT) were admitted to Queen Elizabeth Central Hospital. Their files were reviewed and general physical condition on admission, pre-operative investigations, management and outcome were noted. Results: The mean age of presentation was 4.2 years with an equal distribution between the sexes. The mean BMI was 15 kg/m2 and more than 80% of the patients were either mildly (PCV <33%) or severely anaemic (PCV <24%). All patients presented with abdominal distension. Half of them had additional complaints including abdominal pain, haematuria, dyspnoea, oedema and or weight loss. Thirty-nine out of the forty patients received pre-operative chemotherapy. Of the 36 patients that underwent surgery, 32 underwent total nephrectomy, one a partial nephrectomy, and in three the tumour was irresectable. There were no intra-operative tumour ruptures. Only 15% of the patients completed their post-operative course of chemotherapy. The 1-year survival lies between 25% and 53%. Fifteen of the 36 patients operated were known to have a recurrence. Conclusion: The patients presented in an advanced stage of the disease. Survival rates are disappointing and recurrence rates are high. Some improvement in outcome may be expected with the implementation of more aggressive treatment protocols but early diagnosis, completion of treatment regimens are needed. Pro-active follow-up is essential to measure outcome.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2407    
    Printed205    
    Emailed0    
    PDF Downloaded144    
    Comments [Add]    
    Cited by others 8    

Recommend this journal